Utama › Fibrosis Kistik › Massachusetts › Boston
Kajian klinikal Fibrosis Kistik di Boston, MA
17 kajian untuk Fibrosis Kistik sedang mencari peserta di lokasi dalam dan sekitar Boston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Mengambil pesertaFasa 2
- Massachusetts General Hospital, Boston
- Boston Children's Hospita, Boston
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Mengambil peserta
- Boston Children's Hospital & Harvard University, Boston
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Mengambil pesertaKajian pemerhatian
- Boston Children's Hospital, Boston
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Mengambil pesertaFasa 4
- Boston Children's Hospital, Brigham & Women's Hospital, Boston
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
Mengambil pesertaKajian pemerhatian
- Massachusetts General Hospital, Boston
4D-710 in Adult Patients With Cystic Fibrosis
Mengambil pesertaFasa 2
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Mengambil pesertaFasa 2
- Boston Children'S Hospital, Boston
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Mengambil pesertaFasa 2
- Boston Children's Hospital, Boston
CF Wellness Program
Mengambil peserta
- Boston Children's Hospital, Boston
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Mengambil pesertaKajian pemerhatian
- Massachusetts, Boston
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Mengambil peserta
- Boston Children's Hospital, Boston
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Mengambil pesertaKajian pemerhatian
- Massachusetts General Hospital, Boston
- Boston Children's Hospital/Brigham and Women's Hospital, Boston
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Mengambil pesertaKajian pemerhatian
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Boston Children's Hospital, Boston
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Mengambil pesertaKajian pemerhatian
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
Mengambil peserta
- Boston Children's Hospital, Boston
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Mengambil pesertaFasa 1/2
- Boston Children's Hospital, Brigham & Women's Hospital, Boston
Kajian Fibrosis Kistik di bandar lain
- Birmingham, AL16 kajian
- Philadelphia, PA15 kajian
- Kansas City, KS13 kajian
- Seattle, WA12 kajian
- Baltimore, MD12 kajian
- Denver, CO11 kajian
- Pittsburgh, PA11 kajian
- Dallas, TX11 kajian
- Cincinnati, OH10 kajian
- Los Angeles, CA9 kajian
- Aurora, CO9 kajian
- Minneapolis, MN8 kajian
Kajian lain di Boston
- Kanser Payudara112 kajian
- Kanser Paru-paru Bukan Sel Kecil90 kajian
- Kanser (semua jenis)85 kajian
- Kanser Metastatik63 kajian
- Kanser Kolorektal63 kajian
- Kanser Paru-paru62 kajian
- Kanser Ovari61 kajian
- Kanser Prostat59 kajian
- Depresi52 kajian
- Kanser Endometrium50 kajian
- Kegagalan Jantung44 kajian
- Leukemia Mieloid Akut44 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.